drugset / Trial / NCT00801788

Single Dose Pharmacokinetics of Egalet® Oxycodone

NCT00801788

Phase 1 Completed 16 enrolled Egalet Ltd
RandomizedCrossoverOpen-label

Summary

The purpose of the study is to evaluate the pharmacokinetic profile of different Egalet® oxycodone formulations and compare to a marketed oxycodone product.

Timeline

Start
2008-09
Primary completion
2008-10
Completion
2009-02

Drugs

EvaluationDrugModalityDoseRoute
Comparator Oxycodone Other / unclassified

Indications

No indication recorded.